Clinical trial

Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity

NCT01538225

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-04-01

PhasePHASE3

Study timeline

Study start (unknown)2012-04-01Date precision: month

Registry last updated2014-01-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Sativex®DRUG

PlaceboDRUG

Sponsors & collaborators

Almirall, S.A.lead sponsor

Mapped research locations

MilanItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01538225 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.